Benzophenanthridine alkaloids belong to the benzyl isoquinoline family of alkaloids, which are mainly found in Papaveraceae and Rutaceae. To date, over 100 compounds have been isolated from natural herbal medicines which display a variety of pharmacological functions. In this paper, we have summarized the work since 1980 and our own research on benzophenanthridine alkaloids in terms of their chemical structures and distribution, biosynthesis, biotransformation and metabolism, spectral characteristics, pharmacological activities and toxicity. This review lays the foundation for further research into benzophenanthridine alkaloids and their potential applications.
Benzophenanthridine alkaloids are members of the benzyl isoquinoline alkaloid family and are mainly distributed in the families Papaveraceae and Rutaceae. Shang et al. reported phytochemical and pharmacological investigations into Tibetan medicinal plants of Corydalis and Papaveraceae, which included some benzophenanthridine alkaloids in 2014 [1] [2] , while Krane et al. summarized studies of the isolated benzophenanthridine alkaloids and their spectral data from the first half of the 19th century to 1984 [3] .Following the development of isolation and identification techniques, over 100 benzophenanthridine alkaloids have been reported to date. Some of them, like sanguinarine, chelerythrine and fagaronine, have shown great potential to be developed as new drugs, and their chemical, biological properties, and even methods for their synthesis have been widely reported [4] [5] [6] . In order to assist in the research, development and use of these compounds, we have referred to publications since 1980 and our own research to form a conclusion about the progress that has been made, including chemical structures and distribution, biosynthesis, biotransformation and metabolism, spectral characteristics, pharmacological activities and toxicity. We hope this review will form the foundation for further research on benzophenanthridine alkaloids and their use.
Structure and distribution of benzophenanthridine alkaloids
Benzophenanthridine alkaloids can be classified into three categories, type I (hexahydrobenzo[c]phenanthridine), type II (dihydrobenzo[c]phenanthridine), and type III (quaternary benzo[c]phenathridine). For type I, the molecular skeleton is composed of two aromatic rings and two alkane rings, and the nitrogen is usually connected to the methyl group. For type II, the molecular skeleton is composed of three aromatic rings and one alkane ring, and the nitrogen is also usually connected to the methyl group.8-Hof type II alkaloids is usually substituted with an acetonyl or methoxyl group. Type II alkaloids can be further divided into type II-1 and II-2 according to whether the linkage between C-7 and C-8 is open or not, or whether polymerization at the 8-position has taken place or not. Compared with type II, type III is usually in the form of a quaternary ammonium salt. The structures and numbering are shown in Figure 1 . The benzophenanthridine alkaloids are mainly mainly distributed in Papaveraceae (for example, the genera Chelidonium, Glaucium, and Corydalis) and Rutaceae (genus Zanthoxylum). According to the above classification methods, we have summarized and illustrated the published papers on benzophenanthridine alkaloids and their distributions in Table 1 .
Biosynthesis of benzophenanthridine alkaloids
The biosynthetic route of benzophenanthridine has been determined based on empirical observations and hypothetical deductions. One accepted view is that benzophenanthridine alkaloids originate from a benzyl isoquinoline alkaloid, which shares a common biosynthetic origin beginning with the intermediate (S)-norcoclaurine that is formed through the condensation of dopamine and 4-hydroxyphenylacetaldehyde (4-HPAA) ( Figure 2 ). Dopamine is incorporated into the tetrahydroisoquinoline component, whereas 4-HPAA consists of the C-1-linked benzyl moiety. Hydroxylation of protopine leads to spontaneous ring opening, rearrangement and dehydration to yield the benzophenanthridine alkaloid. As one type of benzyl isoquinoline alkaloid, the diversity of benzophenanthridine alkaloids mainly depends on the functions of enzymes, which have been described by Hagel and Facchini in detail. For example, sanguinarine, which belongs to type III, can be reduced to dihydrosanguinarine, which belongs to type II. In the same way, dihydrosanguinarine can be oxidized to sanguinarine under the action of dihydrobenzophenanthridine oxidase [50] . 
3.Biotransformation and metabolism of benzophenanthridine alkaloids
Until now, there have been only very limited reports aboutthe biotransformation of benzophenanthridine alkaloids. Our group previously tried to obtain more types of benzophenanthridine alkaloids by biotransformation involving fungi in vitro and obtained some new findings. Ambinine, one major benzophenanthridine alkaloid from Corydalis ambigua var. amurensis, can be transformed by Cunninghamella blakesleana AS 3.153 to yield two products, which were identified as ambinoxine and 6-acetylambinine ( Figure 3 ) [51] . Compared with the metabolites biotransformed by fungi, the in vivo metabolites of ambinine seemed more complicated and varied. Our group also investigated the in vivo metabolism of ambinine (M0) in rats. As a result, six metabolites, 6-acetylambinine (M1), 11demethylambinine (M2), 2-demethylambinine (M3), 3demethylambinine (M4), 2,11-didemethylambinine (M5) and 3, 11didemethylambinine (M6) were isolated from rat urine, suggesting that demethylation and acetylation products are the primary metabolites in urine [52] (Figure 4 ). 
3.Spectral characteristics of benzophenanthridine alkaloids

Spectralcharacteristics of hexahydrobenzo[c]phenanthridine(typeI):
The UV spectrum of hexahydrobenzo[c]phenanthridine showed a strong absorbance at 230 and 285 nm with characteristic CD Cotton effects in the 1La band (200-240 nm) and 1Lb band (260-280 nm) regions. A strong positive Cotton effect at 220 nm and a mild negative effect at 280 nm showed the configuration of 6S, 13R and 14R and the opposite corresponded to the enantiomeric arrangement [5, 12, 53] . Yang et al. also reported the characteristic CD spectrum of seven hexahydrobenzophenan-thridine-type alkaloids and confirmed their absolute structures according to this rule [54] .
In 1 H NMR spectra, the proton chemical shifts of H-6, Me-13, H-14 are δ 3.96-4.10 ppm, 1.08-1.15 and 3.25-3.33, respectively, when the absolute configuration is 6R, 13S, 14S or 6S, 13R, and 14R and the substitution groups are -OH, -Me and -H. The chemical shift of N-Me is usually δ 2.15-2.25. If the 6-OH was acetylated, H-6 and N-Me would shift to a lower field at δ 1.25, 0.27-0.30, while Me-13 and H-14 would shift to a higher field at δ 1.27-1.32 and 3.51-3.64, respectively. If 8-H was substituted with a methoxyl group, the chemical shift of N-Me and H-14 would appeared ata lower field of 0.1-1.0 ppm; in the case that C-6, and C-8 formed an oxygen bridge, H-6 and H-14 would shift to a higher field with 0.4 ppm and the most typical characteristic is that H-8 would shift to δ 5. 25-5.30 ; if it were either oxidized or sulfated, H-8 would exhibit a major shift to a lower field ( Table 2 ). In 13 
The spectral characteristics of dihydrobenzo[c]phenanthridine (type II):
Dihydrobenzo[c]phenanthridine displayed strong absorbance at 230, 285 and 340 nm in its UV spectrum. It exhibits characteristic CD Cotton effects in the 1La (200-240 nm) and 1Lb bands (260-280 nm) region in the case of 8-substitution. Yang et al. reported that a strong negative Cotton effect at 219 nm and a mild negative effect at 269 nm were found for the 8S configuration and the opposite corresponded to the enantiomeric arrangement, which has also been confirmed by X-ray single crystal diffraction [55] .
In 1 H NMR spectra, the chemical shift of N-Me is at δ 2.5-2.6, and H-8 at 4.1-4.3. If one of the hydrogens at 8 were substituted with either a methoxyl or an acetonyl group, H-8 would shift to a lower field at δ 0.4-1.4. In 13 C NMR spectra, C-8 usually appears at δ 49, while N-Me is at δ 41-42. However, the chemical shift of C-8 could shift significantly according to the different substituents at position 8 [12, 19, [35] [36] 44 ].
The spectral characteristics of quaternary benzo[c]phenathridine(type III):
In 1 HNMR spectra, the signal of N-Me usually occurs at a relatively higher field, approximately at δ 4.9, and H-8 at around δ 10. In 13 C NMR spectra, the chemical shift of N-Me was approximately at δ 52 and C-8 at about δ 150 [28, 41] .
Pharmacological activities of benzophenanthridine alkaloids
Anti-bacterial and anti-fungal activity:
Seven benzophenanthridine alkaloids, namely, decarine, norchelerythrine, dihydrochelerythrine, 6-acetonyldihydro-chelerythrine, tridecanonchelerythrine, and 6-acetonyldihydronitidine were isolated from Zanthoxylum capense by Luo et al. [42] . They were reported to have antibacterial activity and were more active on Gram-positive than Gram-negativebacteria. It was also been shown that bis-[6-(5,6-dihydrochelerythrinyl)]ether and 8-ethoxychelerythrine display very strong activity against methicillin-resistant Staphylococcus aureus (MRSA), with IC 50 values of 1.0 and 4.0 µM, and no cytotoxicity against Vero cells at 25.0 µg/mL [56] .
Ma et al. isolated several benzophenanthridine alkaloids of type I from the genus Corydalis, and studied their structure and antifungal activity, speculating that the activity was related to the presence of a nitrogen methyl group and the fusion of the B/C ring Chelidonium [47, 49] [57]. Corynoline (10) and acetylcorynoline (15) both showed strong anti-fungal activity, and acetylcorynoline combined with tulipiferine showed stronger activity than acetylcorynoline alone [40] .
Anti-viral activity:
Fagaronine (90) and nitidine (91), which are type III benzophenanthridine alkaloids, have been reported to have an inhibitory effect on HIV-1 reverse transcriptase by Tan et al. [58] . In addition, Cheng et al. found that decarine (72) possessed a clear inhibitory effect on the viral replication of H9 lymphocytes infected with HIV-1, and the EC 50 and TI values were less than 0.1μg/mL and over 226, respectively [59] . This study led to benzophenanthridine alkaloids being considered as potentialanti-HIV candidates.
Fuchino et al. discovered that the benzophenanthridine alkaloids from Bocconia pearcei exhibited a potent inhibitory effect on Leishmania parasites [60] . Furthermore, in a structure-activity relationship study, they found that bulky groups at C-9 and C-10 and N-methyl increased the activity; however, the presence of an 8carbonyl or other substituent group on the B ring and rupture between C-7 and C-8 reduced this activity.
Dihydrochelerythrine separated from Corydails saxicola by Wu et al. exhibited inhibitory effects on hepatitis antigens HbsAg and
HbeAg with an IC 50 <0.05μM and an SI>3.5. Dihydrochelerythrine was shown to have the potential to be developed as an anti-HIV preparation following this research [61] .
Analgesic and anti-inflammatory activity:
Suppressors of glycine transport proteins (GlyT) play primary rolesin regulating pain transmission. Chelerythrine (94) and sanguinarine (95) can suppress pain by selective depression of GlyT 1 rather than GlyT 2 at low concentrations [62] .
Seven benzophenanthridine alkaloids, isolated by Hu et al. from
Zanthorulum nitidum (Roxb.) DC, displayed different degrees of analgesic and anti-inflammatory effects [63] . Comparison of the pharmacological effects indicated that the C=N between position 7 and 8 was the active group. 8-Substitution weakened the antiinflammatory activity, while hydroxylation of the 9, and 10methoxyl groups produced stronger anti-inflammatory activity.
Anti-cancer activity:
The anti-cancer mechanism of benzophenanthridine alkaloids can be classified two ways according to the references reported. In the first, the compounds inhibited mitosis via a reaction of the C=N group on the B ring with the -SH nucleophile, thus displaying anti-proliferative and angiogenesis effects. In the second, compounds affect the enzymatic activities of DNA TopoisomeraseI and Topoisomerase II by implantation into DNA molecules and, thus, retard the fast proliferation of tumor cells.
Wolf and Knipling reported that chelidonine (5) , sanguinarine (95) and chelerythrine (94) have anti-microtubular effects. The mechanism of action of chelidomine was different from that of the other two alkaloids. The action of sanguinarine and chelerythrine were closely related to the C=N group on the B ring, while that of chelidonine was associated with the spatial steric hindrance resulting from the non-planar structures of the B and C rings [64] .
Nitidine chloride was isolated from the root of Zanthoxylum nitidum (Roxb.) DC. By Liu et al., and found to exhibit high inhibitory activities against HepG 2 cells with an inhibition rate of 60.9% at a concentration of 10 mg/kg [65] .The catalytic activity of DNA Topoisomerase I and Topoisomerase II were completely inhibited by nitidine chloride at 6.25 μM/L and 25 μM/L, respectively. It was speculated that DNA Topoisomerase might be one of the targets of nitidine chloride. The mechanism was possibly related to the mutual action of the benzophenanthridine alkaloids and the DNA base via classical non-covalent insertion, which blocked the repair of the DNA signal chain regulated by Topoisomerase I, then influenced the DNA replication of tumor cells, while stimulation of apoptosis of tumor cells reversed the multiple drug resistance of tumor cells.
Philchenkov et al. had a different view of the apoptosis mechanism of benzophenanthridine alkaloids. Both chelidonine and sanguinarine displayed an apoptosis inducing effect on human acute lymphatic T leukemia cell line MT-4 cells. However, chelidonine (5), which does not possess a C=N group and the direct insertion function of DNA, was more active than sanguinarine (95). It has been shown that benzophenanthridine alkaloids induce apoptosis by the mitochondrial pathway, and it has been speculated that the antiproliferation effect was irrelevant to the structure itself and its inserting function into DNA [66] . Figure 5A ); (2) hydroxylation of the methyl group at C-2, 3, and 11 reduced the activity by different degrees in the order of 11-OH>3-OH>2-OH ( Figure 5B ); (3) the activity disappeared accompanied by the loss of N-Me ( Figure 5C ). The structure-activity relationships showed that N-Me, 11-OH and 6-OH were active groups [53, 70] .
Anthelminthic activity:
Antioxidant activity:
Liu et al. reported that the benzophenanthridine alkaloids from the leaves of Corydalis ambigua var. amurensis exhibited antioxidant activity against DPPH and ABTS, which might be due to the phenolic hydroxyl groups. Some of them were even more potent than the positive A B C Figure 5 : The structure and myocardial preservation activity relationships of benzophenanthridine alkaloids control drug, ascorbic acid. In DPPH tests, all alkaloids showed medium clearance activity for DPPH free radicals. Proberberinedisplayed a more potent clearance compared with other kinds of alkaloids. For hexahydrobenzo[c]phenanthridine, the position of the phenolic hydroxyl group is crucial for the antioxidant activity with the order being 3-OH>2-OH>11-OH. However, in the tests for the clearance of ABTS free radicals, proberberine displayed weaker clearance compared with hexahydrobenzo[c]phenanthridine.
Toxicity
Our group assessed the toxicological profile of ambinine and it was found that the LD 50 of ambinine was 41.6 mg/kg for mice following injection. In the repeated-dose toxicity test, ambinine was injected into the tail vein of mice at doses of 1.40 and 2.10 mg/kg for 7 days. The results obtained showed that the relative kidney weight significantly decreased and relative liver weight markedly increased after the injection. Histopathological observations showed that the heart, liver and kidney were changed significantly by the administration of ambinine, showing that ambinine was toxic and this should receive more attention in its future development.
Conclusion
The benzophenanthridine alkaloids has aroused more and more concern due to their wide and significant biological activities. In recent years, benzophenanthridine alkaloids like sanguinarine, chelerythrine and fagaronine all displayed potential prospects for development as new drugs. However, research into benzophenanthridine alkaloids is far from complete. Up to now, only a limited number of benzophenanthridine alkaloids have been isolated, and more compounds need to be discovered with the development of new analysis techniques and their activities need to be carefully screened in order to identify new medicines for the prevention and cure of a variety of diseases. However, their toxicity is an important concern for their further development and this needs more attention in the future.
